Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?
Core Laboratories stock looks cheaper after a 47.1% six-month selloff, but falling earnings and geopolitical pressure keep the near-term case cautious.
Why it matters
Attributed market update with source link for portfolio context.